Comment On: "Botulinum Toxin in the Management of Children with Cerebral Palsy"

Overview

Journal Paediatr Drugs

Specialties Pediatrics
Pharmacology

Date 2019 Oct 5

PMID 31583614

Citations 3

Authors

Katherine Langdon

Lisa Copeland

Priya Edwards

Kate Rodwell

Kim McLennan

Theresa Carroll

Sasaka Bandaranayake

Adam Scheinberg

Mary-Clare Waugh

Heather Burnett

Neil Wimalasundera

Sabine Hennel

Eewei Lim

Steve OFlaherty

Affiliations

Soon will be listed here.

Citing Articles

Muscle in children with cerebral palsy: current evidence, knowledge gaps, and emerging research opportunities : Focus on Cerebral Palsy.

Modlesky C, Matias A Pediatr Res. 2024; .

PMID: 39112788 DOI: 10.1038/s41390-024-03422-x.

Protocol for The Toxin Study: Understanding clinical and patient reported response of children and young people with cerebral palsy to intramuscular lower limb Botulinum neurotoxin-A injections, exploring all domains of the ICF. A pragmatic....

Katchburian L, Oulton K, Main E, Morris C, Carr L BMJ Open. 2021; 11(4):e049542.

PMID: 33883158 PMC: 8061828. DOI: 10.1136/bmjopen-2021-049542.

Authors' Reply to K. Langdon and Colleagues' Comment on: "Botulinum Toxin in the Management of Children with Cerebral Palsy".

Multani I, Manji J, Hastings-Ison T, Khot A, Graham K Paediatr Drugs. 2019; 21(6):497-499.

PMID: 31583615 DOI: 10.1007/s40272-019-00359-1.

References

Howell K, Selber P, Graham H, Reddihough D . Botulinum neurotoxin A: an unusual systemic effect. J Paediatr Child Health. 2007; 43(6):499-501. DOI: 10.1111/j.1440-1754.2007.01122.x. View

OFlaherty S, Janakan V, Morrow A, Scheinberg A, Waugh M . Adverse events and health status following botulinum toxin type A injections in children with cerebral palsy. Dev Med Child Neurol. 2011; 53(2):125-30. DOI: 10.1111/j.1469-8749.2010.03814.x. View

Barber L, Hastings-Ison T, Baker R, Graham H, Barrett R, Lichtwark G . The effects of botulinum toxin injection frequency on calf muscle growth in young children with spastic cerebral palsy: a 12-month prospective study. J Child Orthop. 2014; 7(5):425-33. PMC: 3838523. DOI: 10.1007/s11832-013-0503-x. View

Novak I, McIntyre S, Morgan C, Campbell L, Dark L, Morton N . A systematic review of interventions for children with cerebral palsy: state of the evidence. Dev Med Child Neurol. 2013; 55(10):885-910. DOI: 10.1111/dmcn.12246. View

Multani I, Manji J, Hastings-Ison T, Khot A, Graham K . Botulinum Toxin in the Management of Children with Cerebral Palsy. Paediatr Drugs. 2019; 21(4):261-281. PMC: 6682585. DOI: 10.1007/s40272-019-00344-8. View

Blackmore A, Bear N, Blair E, Langdon K, Moshovis L, Steer K . Predicting respiratory hospital admissions in young people with cerebral palsy. Arch Dis Child. 2018; 103(12):1119-1124. PMC: 6287554. DOI: 10.1136/archdischild-2017-314346. View

Alexander C, Elliott C, Valentine J, Stannage K, Bear N, Donnelly C . Muscle volume alterations after first botulinum neurotoxin A treatment in children with cerebral palsy: a 6-month prospective cohort study. Dev Med Child Neurol. 2018; 60(11):1165-1171. DOI: 10.1111/dmcn.13988. View

Van Campenhout A, Verhaegen A, Pans S, Molenaers G . Botulinum toxin type A injections in the psoas muscle of children with cerebral palsy: muscle atrophy after motor end plate-targeted injections. Res Dev Disabil. 2013; 34(3):1052-8. DOI: 10.1016/j.ridd.2012.11.016. View

Swinney C, Bau K, Burton K, OFlaherty S, Bear N, Paget S . Severity of cerebral palsy and likelihood of adverse events after botulinum toxin A injections. Dev Med Child Neurol. 2018; 60(5):498-504. DOI: 10.1111/dmcn.13686. View

10.

Edwards P, Sakzewski L, Copeland L, Gascoigne-Pees L, McLennan K, Thorley M . Safety of Botulinum Toxin Type A for Children With Nonambulatory Cerebral Palsy. Pediatrics. 2015; 136(5):895-904. DOI: 10.1542/peds.2015-0749. View

11.

Copeland L, Edwards P, Thorley M, Donaghey S, Gascoigne-Pees L, Kentish M . Botulinum toxin A for nonambulatory children with cerebral palsy: a double blind randomized controlled trial. J Pediatr. 2014; 165(1):140-146.e4. DOI: 10.1016/j.jpeds.2014.01.050. View

12.

Valentine J, Davidson S, Bear N, Blair E, Ward R, Thornton A . Botulinum toxin and surgical intervention in children and adolescents with cerebral palsy: who, when and why do we treat?. Disabil Rehabil. 2019; 43(7):936-943. DOI: 10.1080/09638288.2019.1644381. View

13.

Langdon K, Blair E, Davidson S, Valentine J . Adverse events following botulinum toxin type A treatment in children with cerebral palsy. Dev Med Child Neurol. 2010; 52(10):972-3. DOI: 10.1111/j.1469-8749.2010.03695.x. View

14.

Williams S, Reid S, Elliott C, Shipman P, Valentine J . Muscle volume alterations in spastic muscles immediately following botulinum toxin type-A treatment in children with cerebral palsy. Dev Med Child Neurol. 2013; 55(9):813-20. DOI: 10.1111/dmcn.12200. View

15.

Park E, Sim E, Rha D, Jung S . Architectural changes of the gastrocnemius muscle after botulinum toxin type A injection in children with cerebral palsy. Yonsei Med J. 2014; 55(5):1406-12. PMC: 4108831. DOI: 10.3349/ymj.2014.55.5.1406. View